Treatment of CML using IFN-alpha: impact on quality of life. [electronic resource]
- The hematology journal : the official journal of the European Haematology Association 2003
- 253-62 p. digital
Publication Type: Journal Article
1466-4860
10.1038/sj.thj.6200251 doi
Cognition--drug effects Cross-Sectional Studies Drug Evaluation Dyspnea--chemically induced Humans Interferon-alpha--therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive--complications Pain Quality of Life Random Allocation Self-Assessment Sexual Behavior--drug effects Social Behavior Surveys and Questionnaires